Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Methylphenidate

Aliases
Concerta, Concerta, Ritalin, Daytrana, Aptensio XR, Metadate CD, Methylin, Quillivant XR, Jornay PM, Adhansia XR, Cotempla, Daytrana, Methylphenidate Hydrochloride (2 other aliases)
Name
Methylphenidate Hydrochloride
INN Name
Methylphenidate hydrochloride
FDA Approved
Yes

51 clinical trials

39 organizations

73 indications

10 documents

Indication
ADHD
Indication
Attention Deficit Hyperactivity Disorder
Indication
Diabetes Mellitus
Indication
Type 1
Indication
Nicotine Dependence
Indication
Prostate Cancer
Indication
Generalized Anxiety Disorder
Indication
Social Anxiety Disorder
Indication
Panic Disorder
Indication
Agoraphobia
Indication
Pain
Indication
Low Back Pain
Indication
Major Depressive Disorder
Indication
ADHD Combined
Indication
DiGeorge syndrome
Indication
Williams Syndrome
Indication
Fragile X Syndrome
Indication
Insomnia
Indication
Fatigue
Indication
Anxiety
Indication
Cancer
Indication
Post-Traumatic Stress Disorder
Indication
Advanced Malignant Neoplasm
Indication
Metastatic Malignant Neoplasm
Indication
Recurrent Malignant Neoplasm
Indication
Attention Deficit Hyperactivity Disorder Combined Type
Indication
Attention Deficit Hyperactivity Disorder Predominantly Inattentive Type
Indication
ADHD Predominantly Hyperactivity Type
Indication
ADHD, not otherwise specified
Indication
Hematopoietic and Lymphoid Cell Neoplasm
Indication
Malignant Solid Neoplasm
Indication
Sleep Disorder
Indication
Substance Use Disorder
Indication
Cocaine use disorder
Indication
Epilepsy
Indication
Attention-Deficit/Hyperactivity Disorder - Combined Type
Indication
Healthy
Indication
Parkinson's Disease
Indication
Idiopathic
Indication
Childhood Apraxia of Speech
Indication
Decision Making
Indication
Posttraumatic Stress Disorder
Indication
Stress
Indication
Alzheimer's Disease
Indication
Apathy
Indication
Dementia
Indication
PTSD
Indication
stroke
Indication
Chronic Pain
Indication
Alcohol Use Disorder
Indication
Traumatic Brain Injury
Indication
Coma
Indication
Consciousness
Indication
Altered Level of Consciousness
Indication
Anoxic Brain Injury
Indication
Oxygen Toxicity
Indication
Hypercapnia
Indication
Seizure
Indication
solid tumor
Indication
Protocol Specific
Indication
Alzheimer's disease
Indication
Intellectual disability
Indication
Down syndrome
Indication
Anxiety Disorder
Indication
Advanced Cancer
Indication
Neurodevelopmental Disorders
Indication
Cerebral Palsy
Indication
Obesity
Indication
Morbid
Indication
Cocaine Use Disorder
Indication
KBG syndrome
Indication
Attention-deficit/hyperactivity disorder
Indication
Autism Spectrum Disorder
Clinical trial
A Randomized, Parallel, Double-Blind Efficacy and Safety Study of Biphentin Methylphenidate HCl Extended Release Capsules Compared to Placebo in Children and Adolescents 6 to 18 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Completed, Estimated PCD: 2012-02-01
Clinical trial
A Randomized, Double-Blind Study of the Time Course of Response to Biphentin® Methylphenidate Hydrochloride ER Capsules Compared to Placebo in Children 6 to 12 Years With Attention Deficit Hyperactivity Disorder in Analog Classroom Setting
Status: Completed, Estimated PCD: 2011-06-18
Clinical trial
LAMAinDiab - Lisdexamphetamine vs Methylphenidate for Pediatric Patients With ADHD and Type 1 Diabetes - a Randomized Cross-over Clinical Trial
Status: Not yet recruiting, Estimated PCD: 2027-12-01
Clinical trial
Orexin's Role in The Neurobiology of Substance Use Disorder
Status: Recruiting, Estimated PCD: 2027-12-31
Clinical trial
Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy
Status: Active (not recruiting), Estimated PCD: 2025-02-01
Clinical trial
A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity
Status: Completed, Estimated PCD: 2022-09-30
Clinical trial
The Neural Correlates of and Effects of Methylphenidate on Acute Pain Dynamics
Status: Completed, Estimated PCD: 2024-04-26
Clinical trial
Psilocybin and Affective Function in Chronic Lower Back Pain Depression
Status: Recruiting, Estimated PCD: 2026-07-30
Clinical trial
Anomalous Motor System Physiology in Attention Deficit Hyperactivity Disorder: Biomarker Validation and Modeling Domains of Function
Status: Recruiting, Estimated PCD: 2026-02-01
Clinical trial
The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors
Status: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Children and Adolescents With ADHD
Status: Withdrawn, Estimated PCD: 2028-12-01
Clinical trial
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
Status: Recruiting, Estimated PCD: 2027-02-28
Clinical trial
The Relation Between Attentional, Sensory and Emotional Dysregulation in Adults With Posttraumatic Stress Disorder: a Double-blind, Placebo-controlled Randomized Controlled Trial of the Combined Treatment With Reboxetine and Methylphenidate
Status: Recruiting, Estimated PCD: 2024-02-01
Clinical trial
A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy
Status: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
The Effect of Methylphenidate (Ritalin IR) Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Completed, Estimated PCD: 2014-04-01
Clinical trial
Multimodal Therapy for the Treatment of Sleep Disturbance in Patients With Cancer
Status: Active (not recruiting), Estimated PCD: 2025-12-31
Clinical trial
Targeting Neural, Behavioral and Pharmacological Mechanisms of Drug Memories in Drug Addiction With Methylphenidate
Status: Recruiting, Estimated PCD: 2024-08-31
Clinical trial
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits: a Randomized, Double-blind, Placebo-controlled Trial
Status: Recruiting, Estimated PCD: 2027-09-30
Clinical trial
Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD
Status: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy Humans
Status: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease: A Single Center, Randomized Pilot Study
Status: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
The Neuroprotective Effects of Methylphenidate and Atomoxetine in Children With Attention Deficit Hyperactivity Disorder: A Lipidomic Study
Status: Completed, Estimated PCD: 2021-01-25
Clinical trial
A Phase II Proof-of-concept Trial of Methylphenidate in Children With Apraxia of Speech: a Double-blind, Randomised, Placebo-controlled, Cross-over Trial
Status: Recruiting, Estimated PCD: 2025-07-01
Clinical trial
Studying the Role of Brain Molecules for Decision Making
Status: Completed, Estimated PCD: 2021-12-13
Clinical trial
Randomized Placebo-Controlled Trial of Methylphenidate for the Treatment of Post-Traumatic Stress Disorder With Associated Neurocognitive Complaints
Status: Recruiting, Estimated PCD: 2026-07-06
Clinical trial
Differences by Sex and Genotype in the Effects of Stress on Executive Functions
Status: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Status: Withdrawn, Estimated PCD: 2011-12-20
Clinical trial
A Randomized Placebo-controlled Trial of Methylphenidate in Veterans With a Diagnosis of Post Traumatic Stress Disorder and Recent Cerebral Stroke.
Status: Recruiting, Estimated PCD: 2026-09-30
Clinical trial
The Role of Dopamine in the Central Neural Signature of Chronic Pain
Status: Recruiting, Estimated PCD: 2024-12-22
Clinical trial
A Novel Drug Combination for Alcohol-Use Disorders: A Human Laboratory Study
Status: Completed, Estimated PCD: 2023-03-15
Clinical trial
Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness - A Phase 1 Study
Status: Completed, Estimated PCD: 2024-04-01
Clinical trial
Applied Physiology of Oxygen Toxicity: Mechanisms in Humans
Status: Recruiting, Estimated PCD: 2026-03-01
Clinical trial
Apathy in Dementia Methylphenidate Trial 2
Status: Completed, Estimated PCD: 2020-07-15
Clinical trial
Double-Blind Randomized Trial of Methylphenidate for Alleviation of Fatigue and Lethargy Associated With Interferon Alpha 2b
Status: , Estimated PCD: 2002-05-01
Clinical trial
A Pilot, Multiple Crossover, Randomized Block Sequence, Double-Blind, Placebo-Controlled Trial for Use of Methylphenidate for Cognitive and Behavioral Symptoms in Mild Cognitive Impairment and Dementia
Status: Completed, Estimated PCD: 2021-08-30
Clinical trial
Sensitivity of the NIH Toolbox Cognition Battery to Stimulant Treatment in Intellectual Disabilities
Status: , Estimated PCD: 2025-09-29
Clinical trial
Investigating Fundamental Mechanisms of Mental and Physical Fatigue Using Neurotransmitter Reuptake Inhibitors and Electroencephalography: a Randomized Counterbalanced Crossover Trial
Status: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Cognitive vs. Emotional Psycho-Pharmacological Manipulations of Fear vs. Anxiety
Status: Completed, Estimated PCD: 2021-10-07
Clinical trial
A Randomized Controlled Trial of Methylphenidate and a Nursing Telephone Intervention (NTI) for Fatigue in Advanced Cancer Patients
Status: Completed, Estimated PCD: 2021-11-22
Clinical trial
Effect of Central Nervous System Stimulants on Physical Function in Children With Cerebral Palsy: A Pilot Randomized Controlled Trial
Status: Not yet recruiting, Estimated PCD: 2025-02-01
Clinical trial
Understanding the Mechanism of Action of Methylphenidate in ADHD: A Computational Psychiatry Approach
Status: Not yet recruiting, Estimated PCD: 2026-06-01
Clinical trial
Bariatric Surgery and Pharmacokinetics Methylphenidate: BAR-MEDS Methylphenidate
Status: Recruiting, Estimated PCD: 2026-10-01
Clinical trial
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the Quantified Behavior Test in Patients With Untreated ADHD and Substance Use Disorder
Status: Completed, Estimated PCD: 2021-06-01
Clinical trial
Intervention for Teens With ADHD and Substance Use
Status: Terminated, Estimated PCD: 2021-08-01
Clinical trial
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Status: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
1403013567
Status: Terminated, Estimated PCD: 2014-06-09
Clinical trial
Methylphenidate and Response to Alcohol Cues (MARA) Pilot Study
Status: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
A Combination Therapy to Treat Cancer-Related Fatigue - NCI R01
Status: Recruiting, Estimated PCD: 2026-11-30
Clinical trial
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
Status: , Estimated PCD: 2024-09-01
Clinical trial
Effectiveness of Methylphenidate in Children and Adolescents With KBG Syndrome: An N-of-1 Series
Status: Not yet recruiting, Estimated PCD: 2027-01-01
Clinical trial
Open-Label Treatment Trial to Assess the Short-Term Tolerability, Safety, and Efficacy of Methylphenidate Hydrochloride Extended-Release Liquid Formulation in High-Functioning Autism Spectrum Disorder Adults With Attention-Deficit/Hyperactivity Disorder
Status: Completed, Estimated PCD: 2018-01-01
Document
DailyMed Label: Methylphenidate Hydrochloride
Organization
Physicians Total Care, Inc.
Organization
bryant ranch prepack
Document
DailyMed Label: Concerta
Organization
Camber Pharmaceutical Inc
Organization
XLCare Pharmaceuticals Inc.
Organization
XLCare Pharmaceuticals, Inc.
Organization
Camber Pharmaceuticals, Inc.
Organization
NORTHSTAR RX LLC
Document
DailyMed Label: Methylphenidate Hydrochloride (LA)
Organization
Mayne Pharma Inc.
Organization
Lannett Company, Inc.
Organization
Rising Pharma Holdings, Inc.
Organization
Ascend Laboratories, LLC
Organization
Ascent Pharmaceuticals, Inc.
Document
DailyMed Label: methylphenidate hydrochloride CD
Organization
Eywa Pharma Inc.
Organization
QUAGEN PHARMACEUTICALS LLC
Document
DailyMed Label: Quillivant
Organization
NextWave Pharmaceuticals, Inc
Document
DailyMed Label: JORNAY PM
Organization
Ironshore Pharmaceuticals Inc.
Organization
Janssen Pharmaceuticals, Inc.
Organization
Tris Pharma Inc
Organization
Sun Pharmaceutical Industries, Inc.
Organization
Trigen Laboratories, LLC
Organization
American Health Packaging
Organization
Patriot Pharmaceuticals, LLC.
Organization
Solco Healthcare US,LLC
Organization
SpecGx LLC
Organization
Amneal Pharmaceuticals of New York LLC
Document
DailyMed Label: Ritalin
Organization
Novartis Pharmaceuticals Corporation
Document
DailyMed Label: RELEXXII
Organization
Vertical Pharmaceuticals, LLC
Organization
Golden State Medical Supply, Inc.
Organization
Teva Pharmaceuticals USA, Inc.
Document
DailyMed Label: Metadate CD
Organization
Granules Pharmaceuticals Inc.
Organization
Nivagen Pharmaceuticals, Inc.
Organization
Actavis Pharma, Inc.
Organization
Lupin Pharmaceuticals,Inc.
Organization
Aytu BioPharma, Inc.
Organization
Neolpharma, Inc.
Organization
KVK-Tech, Inc.
Organization
AvPAK
Document
DailyMed Label: APTENSIO XR
Organization
Rhodes Pharmaceuticals L.P.
Organization
UCB Pharma, Inc.